Scientists have found that proteins at the blood-brain barrier tend to pump out riluzole, the only FDA-approved drug for Amyotrophic lateral sclerosis (ALS) or Lou Gehrig's disease, limiting the drug's effectiveness, through research in mice. However, when the investigators blocked these proteins, the effectiveness of riluzole increased and the animals experienced improved muscle function, slower disease progression and prolonged survival.
The findings suggest that blocking these transporter proteins at the blood-brain barrier might improve delivery and ultimately, efficacy of drugs used to treat ALS and other brain disorders.
Amyotrophic Lateral Sclerosis (ALS)
Find out more about the degenerative disease- Amyotrophic lateral sclerosis.
Advertisement
"This is a proof-of-principle study that sheds light into a basic pathological mechanism at play in ALS that negatively affects our ability to deliver drugs efficiently," said Dr. Piera Pasinelli, senior author of the Annals of Clinical and Translational Neurology study. "If the findings hold true in clinical trials, we'll have the opportunity not only to improve the efficacy of an already approved ALS drug, but also to design better therapeutic strategies moving forward."
Source: Eurekalert
Ice Bucket Challenge - A Global Awareness Initiative for Amyotrophic Lateral Sclerosis (ALS)
Ice Bucket Challenge, aimed at creating awareness about Amyotrophic Lateral Sclerosis, has collected $88.5 million till August 26.
Advertisement
 Clinical TrialsClinical trials are experiments that yield useful information to clinicians if a particular treatment is of any value to a patient. | Advertisement
|
Bell's Palsy
Bell''s palsy is facial nerve disorder that causes weakness of the muscles on one side of the face. Its cause is unknown but most people make a full recovery within 8 to 12 weeks.
Advertisement
Recommended Reading
Latest Mental Health News
Americans exhibit high intelligence in one IQ category despite lower scores in others according to a new study.
New study confirms a drop in suicide rates across 15 European countries, while Turkey sees a significant increase.
Lesbian, gay, and bisexual youth experience sleep problems due to depression, stress, and family conflict.
Are mental health services important for tuberculosis treatment? Integrating mental health services into the Tuberculosis program can improve treatment completion.
Sleep interventions such as melatonin treatment could be considered to reduce the risk of self-harm in young females with depression and anxiety, instead of medications.